Intco Medical Technology (300677.SZ): The company is currently operating at full production and sales.

On March 18, Gelonghui reported that Intco Medical Technology (300677.SZ) stated on the investor interaction platform that the company will continue to closely monitor the innovation and application of emerging technologies. The company is currently maintaining full production and sales.

Gelonghui Finance03:23 ET

Investors Aren't Entirely Convinced By Intco Medical Technology Co., Ltd.'s (SZSE:300677) Earnings

Simply Wall StFeb 28 20:02 ET

Can Mixed Fundamentals Have A Negative Impact on Intco Medical Technology Co., Ltd. (SZSE:300677) Current Share Price Momentum?

Simply Wall StFeb 13 19:13 ET

Intco Medical Technology (300677.SZ): has cumulatively repurchased 0.3033 million shares.

On February 5, Gelonghui reported that Intco Medical Technology (300677.SZ) announced that as of January 31, 2025, the company has repurchased a total of 0.3033 million shares through a special securities account for share buybacks via centralized bidding trading, accounting for 0.0469% of the company's total share capital (based on a total share capital of 646,193,496 shares as of January 27, 2025). The highest Fill Price was 21.62 yuan/share, the lowest Fill Price was 20.99 yuan/share, and the total amount of the transaction was 6.4676 million yuan (excluding transaction costs).

Gelonghui FinanceFeb 5 05:00 ET

Intco Medical Technology (300677.SZ) announced an earnings forecast, expecting net income for the year 2024 to be between 1.2 billion and -1.5 billion yuan, representing a significant year-on-year growth of 213.32% to 291.65%.

Intco Medical Technology (300677.SZ) released its performance forecast for 2024, with the company expecting...

Zhitong FinanceJan 23 05:04 ET

British Healthcare: 2024 Annual Results Forecast

SZSIJan 23 04:26 ET · Announcements

Is Intco Medical Technology (SZSE:300677) A Risky Investment?

Simply Wall StDec 28, 2024 19:39 ET

Intco Medical Technology's (SZSE:300677) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Simply Wall StNov 27, 2024 20:30 ET

Fewer Investors Than Expected Jumping On Intco Medical Technology Co., Ltd. (SZSE:300677)

Simply Wall StNov 9, 2024 19:56 ET

Intco Medical Technology (300677.SZ): The cumulative repurchased 0.3033 million shares.

Intco Medical Technology (300677.SZ) announced that, as of October 31, 2024, the company has repurchased a total of 303,300 shares through a share repurchase dedicated securities account via centralized auction trading, accounting for 0.0469% of the total share capital (based on the total share capital of 646,185,763 shares as of October 31, 2024). The highest fill price was 21.62 yuan/share, the lowest fill price was 20.99 yuan/share, and the total fill amount was RMB 6,467,649.00 (excluding trading expenses).

Gelonghui FinanceNov 1, 2024 03:55 ET

British Healthcare: Report for the third quarter of 2024

SZSIOct 28, 2024 12:00 ET · Announcements

Express News | Intco Medical Technology Says Q3 Net Profit up 166.5% Y/Y

ReutersOct 28, 2024 06:08 ET

Individual Investors Invested in Intco Medical Technology Co., Ltd. (SZSE:300677) up 5.9% Last Week, Insiders Too Were Rewarded

Simply Wall StOct 22, 2024 22:21 ET

Intco Medical Technology Co., Ltd.'s (SZSE:300677) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Simply Wall StOct 4, 2024 19:32 ET

Selected Announcement: Oulai New Materials: plans to invest no less than 2.59 billion yuan to build the Oulai New Materials Mingyue Lake Industrial Park project; Intco Medical Technology: plans to repurchase company shares worth 80 million to 0.12 billion

Beijing Tianyishangjia New Material Corp.: Tianrendahe intends to cooperate with Xinghe Power in the research and development and manufacturing of solid and liquid launch vehicle related components.

Gelonghui FinanceSep 19, 2024 10:06 ET

GLE.FE Announcement Selection | Oulai New Materials: Intends to invest no less than 2.59 billion yuan to build Oulai New Materials Mingyue Lake Industrial Park project; Intco Medical Technology: Intends to repurchase company shares worth 80 million yuan t

[Company Business Data] Yunda Holding (002120.SZ): In August, the express service business income was 3.917 billion yuan, a year-on-year increase of 11.41%. sto express co.,ltd. (002468.SZ): In August, the express service business income was 3.873 billion yuan, a year-on-year increase of 21.5%. YTO Express Group (600233.SH): In August, the express product income was 4.908 billion yuan, a year-on-year increase of 20.67%. guilin layn natural ingredients corp. (002166.SZ): Net income is expected to increase by 100%-150% in the first three quarters. [Contract Projects] Oulei New Materials (688530.SH): Intends to be no less than 2.59 billion.

Gelonghui FinanceSep 19, 2024 10:06 ET

intco medical technology (300677.SZ): plans to repurchase company shares worth 80 million to 0.12 billion yuan.

On September 19, Intco Medical Technology (300677.SZ) announced that it plans to repurchase a total amount of shares not less than RMB 80 million and not exceeding RMB 120 million, with a maximum repurchase price of RMB 26.66 per share, for the purpose of implementing employee stock ownership plans and/or stock-based incentives.

Gelonghui FinanceSep 19, 2024 07:15 ET

The threat of additional tariffs looms high, intco medical technology's stock price drops by 20%, What are the prospects for its North American layout?

①Today, Intco Medical Technology's stock fell 20 centimeters in the intraday trading session. An employee from the securities department of Intco Medical Technology stated, 'This is because the United States announced the impact of increasing tariffs on some Chinese commodities under Section 301.' ②The employee said that the proportion of the U.S. market in the company's revenue is about 35%, which may pose challenges to the company's performance in the short term. However, the overall potential of the U.S. market is still significant, and the company still plans to increase its efforts to expand into the North American market.

cls.cnSep 18, 2024 02:13 ET

Solid Earnings May Not Tell The Whole Story For Intco Medical Technology (SZSE:300677)

Simply Wall StSep 4, 2024 21:22 ET

Intco Medical Technology (SZSE:300677) May Have Issues Allocating Its Capital

Simply Wall StSep 3, 2024 21:18 ET